K2 Principal Fund, L.P. Teva Pharmaceutical Industries LTD Transaction History
K2 Principal Fund, L.P.
- $307 Million
- Q4 2024
A detailed history of K2 Principal Fund, L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, K2 Principal Fund, L.P. holds 50,000 shares of TEVA stock, worth $774,500. This represents 0.1% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$774,500% of portfolio
0.1%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TEVA
# of Institutions
677Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$666 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$604 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$568 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$440 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$421 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $17.2B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...